Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By



Set Alert for Pharmaceuticals

GALVmed receives funding approval for Tryps Phase 3 program

GALVmed has received funding totaling $19 million for its Improved Tools for the Control of Animal African Trypanosomosis, Phase 3 (Tryps 3) program.

Pharmaceuticals R&D

Submit your nominations for the Animal Pharm Awards 2018

Subscribers have five weeks to nominate their company and their innovations in the Animal Pharm Awards for 2018.

Companion Animals Food Animals

Zomedica loss down in Q3, up over nine months

US firm Zomedica Pharmaceuticals has seen its net loss in the third quarter of 2018 decrease.

Financial Results Pharmaceuticals

Zoetis receives FDA authorization for poultry combination

Zoetis has gained US FDA approval for its Cyden (clopidol) and Lincomix (lincomycin) combination feed additive.

Zoetis Product Approvals

Ceva gains CVMP positive opinion for canine cardiovascular product

Ceva Santé Animale's Isemid (torasemide) has moved a step closer to European authorization after gaining a recommendation for marketing approval.

Product Approvals Pharmaceuticals

Companion Animal Health advances canine tumor ablation tech to US commercialization

Litecure has advanced towards commercialization of Companion Nano Therapy with a potential launch date in the US of 2019.

United States Pharmaceuticals

US steps up international fight over livestock growth promoters

A global clash over the use of beta-agonist livestock growth promoters is once again prompting US criticism of international organizations.

United States Pharmaceuticals

KindredBio sees atopic dermatitis shift to biologics, gains positive results in mAb study

Kindred Biosciences has gained positive top-line results from a pilot effectiveness study of its interleukin-31 (IL-31) antibody for the treatment of canine atopic dermatitis.

Canine Kindred Biosciences

Phyto signs up US distributor for CBD products

Phyto Animal Health has signed an exclusive distribution agreement with Liiv Organics to sell its cannabidiol (CBD) products in the US.

Deals Pharmaceuticals

AnimalhealthEurope welcomes plenary adoption of new veterinary drug rules

Industry body AnimalhealthEurope has welcomed new rules for animal medicines signed off by European Parliament.

Policy & Regulation Europe

Study suggests ELIAS can boost survival time with canine cancer immunotherapy

ELIAS Animal Health claims a new study suggests its experimental cancer immunotherapy "may improve survival times in dogs with cancer".

R&D Cancer

Anterra Capital: Now is the right time to invest in animal health

Several key trends have aligned to make the animal health and welfare sector a truly attractive prospect, according to venture capital investor Anterra Capital. 

Investments R&D
See All